TNGX Smart Money
Tango Therapeutics, Inc.
1W: -9.3%
1M: -5.8%
3M: -11.4%
YTD: +156.3%
1Y: +205.2%
3Y: +203.6%
5Y: +79.0%
$22.89
+0.69 (+3.13%)
Pre-Market: $23.45 (+0.56, +2.45%)
Weekly Expected Move ±12.7%
$17
$20
$23
$26
$29
Credit Risk of going bust: lower than 53% of companies Debt: 0.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.04 (down 99.8%), Tango Therapeutics, Inc. would be worth roughly what it owes.
Total debt $32.0M against a stock market value of $3.86B.
Distance to default 5.39 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $17.5M (short-term plus half of long-term), stock volatility 93.4%; Altman Z'' 25.07. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.04 (down 99.8%), Tango Therapeutics, Inc. would be worth roughly what it owes.
Total debt $32.0M against a stock market value of $3.86B.
Distance to default 5.39 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $17.5M (short-term plus half of long-term), stock volatility 93.4%; Altman Z'' 25.07. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026273
Institutions Holding
+48 vs prior
166.2%
Ownership
+69.61%
82
New
101
Increased
77
Reduced
22
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Crystal Adam | officer: president, r&d | S-Sale | 600 | $25.32 | $15K | Filing |
| 2026-10-01 | Crystal Adam | officer: president, r&d | S-Sale | 26,400 | $24.45 | $646K | Filing |
| 2026-09-22 | Newcomb Jessica | officer: principal accounting officer | S-Sale | 2,400 | $25.17 | $60K | Filing |
| 2026-09-22 | Newcomb Jessica | officer: principal accounting officer | S-Sale | 5,100 | $23.97 | $122K | Filing |
| 2026-09-22 | Newcomb Jessica | officer: principal accounting officer | S-Sale | 700 | $22.80 | $16K | Filing |
| 2026-09-01 | Crystal Adam | officer: president, r&d | S-Sale | 27,000 | $22.37 | $604K | Filing |
| 2026-08-03 | Crystal Adam | officer: president, r&d | S-Sale | 21,733 | $27.35 | $594K | Filing |
| 2026-08-03 | Crystal Adam | officer: president, r&d | S-Sale | 5,267 | $26.79 | $141K | Filing |
| 2026-07-01 | Crystal Adam | officer: president, r&d | S-Sale | 7,371 | $30.25 | $223K | Filing |
| 2026-07-01 | Crystal Adam | officer: president, r&d | S-Sale | 19,629 | $29.34 | $576K | Filing |
| 2026-06-19 | Azelby Robert | director | A-Grant/Award | 5,740 | $— | $0 | Filing |
| 2026-06-05 | Rothenberg Mace | director | A-Grant/Award | 4,000 | $— | $0 | Filing |
| 2026-06-05 | Calhoun Lesley Ann | director | A-Grant/Award | 4,000 | $— | $0 | Filing |
| 2026-06-05 | Ketchum John B | director | A-Grant/Award | 4,000 | $— | $0 | Filing |
| 2026-06-05 | Lee Sung | director | A-Grant/Award | 570 | $— | $0 | Filing |
| 2026-06-01 | Crystal Adam | officer: president, r&d | S-Sale | 20,860 | $23.06 | $481K | Filing |
| 2026-06-01 | Crystal Adam | officer: president, r&d | S-Sale | 6,140 | $22.25 | $137K | Filing |
| 2026-05-01 | Gall Matthew | officer: chief financial officer | A-Grant/Award | 40,000 | $— | $0 | Filing |
| 2026-05-01 | Crystal Adam | officer: president, r&d | S-Sale | 1,100 | $22.00 | $24K | Filing |
| 2026-05-01 | Crystal Adam | officer: president, r&d | S-Sale | 25,900 | $21.19 | $549K | Filing |
| 2026-04-29 | Lee Sung | director | A-Grant/Award | 12,300 | $— | $0 | Filing |
| 2026-04-15 | Crystal Adam | officer: president, r&d | S-Sale | 38,460 | $25.00 | $962K | Filing |
| 2026-04-01 | Crystal Adam | officer: president, r&d | S-Sale | 27,000 | $21.20 | $572K | Filing |
| 2026-03-25 | Crystal Adam | officer: president, r&d | S-Sale | 12,000 | $20.11 | $241K | Filing |
| 2026-02-25 | Crystal Adam | officer: president, r&d | S-Sale | 54,345 | $12.77 | $694K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 13,900,620 | $435M | +600,000 | 2026-06-30 | Filing |
| BlackRock, Inc. | 12,438,444 | $389M | +3,690,399 | 2026-06-30 | Filing |
| FMR LLC | 12,333,339 | $386M | +2,427,420 | 2026-06-30 | Filing |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 12,277,000 | $384M | +3,179,589 | 2026-06-30 | Filing |
| Boxer Capital Management, LLC | 10,876,219 | $340M | — | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 9,980,620 | $312M | +4,904,228 | 2026-06-30 | Filing |
| TCG Crossover Management, LLC | 9,081,201 | $284M | -1,449,870 | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 6,357,523 | $199M | +2,347,844 | 2026-06-30 | Filing |
| Siren, L.L.C. | 6,179,364 | $193M | +522,259 | 2026-06-30 | Filing |
| STATE STREET CORP | 5,979,806 | $187M | +1,327,912 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,957,348 | $186M | +795,917 | 2026-06-30 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,600,000 | $175M | -7,209,485 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 5,056,352 | $158M | +5,056,352 | 2026-06-30 | Filing |
| Deep Track Capital, LP | 4,200,000 | $131M | +1,450,000 | 2026-06-30 | Filing |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4,190,611 | $131M | +43,798 | 2026-06-30 | Filing |
| Woodline Partners LP | 4,000,567 | $125M | -3,999,446 | 2026-06-30 | Filing |
| TRV GP IV, LLC | 6,374,574 | $120M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,742,791 | $117M | +1,067,014 | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 3,377,000 | $106M | +2,568,847 | 2026-06-30 | Filing |
| Seven Fleet Capital Management LP | 3,228,144 | $96M | +2,726,132 | 2026-06-30 | Filing |